Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catherine S. Tripp
RPC4046, a Novel Anti-Interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 Α1 and Α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-In-Human Study
Advances in Therapy
Medicine
Pharmacology
Related publications
Specific Targeting of Human Interleukin (IL)-13 Receptor Α2-Positive Cells With Lentiviral Vectors Displaying IL-13
Human gene therapy methods
Applied Microbiology
Biotechnology
Genetics
Pharmacology
Molecular Medicine
Identification, Purification, and Characterization of a Soluble Interleukin (IL)-13-binding Protein
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Anti-Il-7 Receptor Α Monoclonal Antibody (GSK2618960) in Healthy Subjects - A Randomised, Double-Blind Placebo-Controlled Study
British Journal of Clinical Pharmacology
Pharmacology
Induction of the IL-13 Receptor Α2-Chain by IL-4 and IL-13 in Human Keratinocytes: Involvement of STAT6, ERK and P38 MAPK Pathways
Oncogene
Cancer Research
Genetics
Molecular Biology
Interleukin (IL) 4 and IL-13 Act on Human Lung Fibroblasts. Implication in Asthma.
Journal of Clinical Investigation
Medicine
Analysis of Antitumor Activity of an Interleukin-13 (IL-13) Receptor-Targeted Cytotoxin Composed of IL-13 Antagonist and Pseudomonas Exotoxin
Clinical Cancer Research
Cancer Research
Oncology
A Novel Chimeric Protein Composed of Interleukin 13 andPseudomonasExotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Muscle-Derived IL-6 Is Not Regulated by IL-1 During Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study
PLoS ONE
Multidisciplinary
Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody
Journal of Allergy and Clinical Immunology
Allergy
Immunology
